Personal and Home Care Products
CIRS Group
Medical Devices
C&K Testing
Carbon Neutrality

China NMPA is Collecting Public Comments on the Measures for the Administration of Cosmetics Inspection (Draft)

from CIRS by


To implement the Cosmetics Supervision and Administration Regulations (CSAR) and the Measures for the Supervision and Administration of Cosmetics Production and Operation, the National Medical Products Administration (NMPA) has organized to draft the Measures for the Administration of Cosmetics Inspection and released it for public consultation. Any comments are welcomed between October 19 and November 10, 2023.

According to the Measures for the Administration of Cosmetics Inspection, the NMPA is responsible for the management of cosmetics inspection nationwide. The departments accountable for drug supervision and control at or above the county level are responsible for the inspection and management of cosmetics in their respective administrative regions.

The department responsible for drug supervision and management, as well as the legally established or designated inspection agencies (hereinafter referred to as "inspection agencies"), carry out inspection work by laws, regulations, rules, etc. According to the nature and purpose of the examination, cosmetic examination can be divided into license examination, routine examination, causal examination, and other examinations.

If you need any assistance or have any questions, please get in touch with us via


We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.

Contact Us
+353 1 477 3710 (EU)
+44 20 3239 9430 (UK)
+1 703 520 1420 (USA)
+86 571 8720 6574 (CN)
+82 2 6347 8816 (KR)